Melike Karaçam Doğan

Melike Karaçam Doğan

Auto-generated profile, based on publicly available information

Melike Karaçam Doğan

Ankara Bilkent City Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
EMEmre Mutlu
Emre Mutlu
MDMelike Karaçam Doğan
Melike Karaçam Doğan
AEAygün Ertuğrul
Aygün Ertuğrul
AYA. Elif Anıl Yağcıoğlu
A. Elif Anıl Yağcıoğlu
Background: Combining clozapine with a long-acting injectable antipsychotic (LAI) or using different, nonstandard formulations of the compound may improve treatment outcomes. We aimed to investigate the utility of the clozapine-LAI combination and different formulations of clozapine for compliance problems of clozapine treatment, and to describe a case series on the combined treatment. Procedures: We conducted a PubMed search with no date restriction. The number and length of hospitalizations, the results of clinical scales, and adverse events were recorded. We also present a case series of 18 patients using the clozapine-LAI combination. Data were collected from the medical charts and electronic records. Results: We extracted 9 records describing the use of the clozapine-LAI combination. The case reports and mirror-image studies showed a significant reduction in the number of hospitalizations, length of hospital stays, and number of visits to the emergency department on the combined treatment with no serious adverse events. We included 11 articles for clozapine formulations. The case reports and retrospective data suggested that short-acting intramuscular clozapine was often well tolerated and resulted in an increased acceptance of oral clozapine in the acute phase of illness. In our case series, illness severity and the number of hospitalization per year significantly decreased after the combined treatment, besides a significant improvement in the functioning scores. Hyperprolactinemia and extrapyramidal side effects were reported due to concomitant LAIs. Conclusions: Despite the encouraging evidence, the present data are preliminary and mostly based on retrospective studies, and oral-dissolving tablets or oral liquid formulations of clozapine have insufficient evidence for clinical practice. Well-designed, controlled, follow-up studies are needed for both clozapine-LAI combination and different formulations of clozapine.

3 February 2023 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
MDMelike Karaçam Doğan
Melike Karaçam Doğan
NENilgün Oktar Erdoğan
Nilgün Oktar Erdoğan
AEAygün Ertuğrul
Aygün Ertuğrul
AYAyşe Elif Anil Yağcioğlu
Ayşe Elif Anil Yağcioğlu
MYM. Kâzim Yazici
M. Kâzim Yazici

20 February 2026 in European Psychiatry
Verified
Journal Article
Open access
PDF file
MDMelike Karaçam Doğan
Melike Karaçam Doğan
TPThanavadee Prachason
Thanavadee Prachason
LFLaura Fusar-Poli
Laura Fusar-Poli
CMClaudia Menne-Lothmann
Claudia Menne-Lothmann
JDJeroen Decoster
Jeroen Decoster
SGSinan Guloksuz
Sinan Guloksuz
Background: Sex differences in psychosis pathoetiology are insufficiently understood. This study explores how childhood adversity (CA) and coping mechanisms relate to psychosis expression (PE) across males and females in the general population. Methods: Data from the TwinssCan project (males: n = 312; females: n = 478) were used. The Childhood Trauma Questionnaire assessed CA domains. The Utrecht Coping List assessed coping strategies. Psychosis expression was assessed using the Community Assessment of Psychic Experiences (CAPE). Mixed linear regression analyses examined sex-stratified associations of CAPE scores with CA, coping strategies, and their interactions. Results: Emotional abuse (EA) was associated with increased total CAPE scores (T-CAPE), explaining the greatest variance among CA across sexes. Sex-specific effects showed that sexual abuse (SA) and physical abuse (PA) were linked to higher T-CAPE in females, whereas physical neglect (PN) was linked to higher T-CAPE in males. Passive-reacting was associated with increased T-CAPE, explaining the greatest variance among coping styles across both sexes. Sex-specific effects showed that, in females, seeking social support was linked to decreased T-CAPE, while emotional expression increased it. The only sex-shared interaction effect was between reassuring thoughts and emotional neglect (EN), associated with decreased T-CAPE. In females, social support (× PA/PN/EA), reassuring thoughts (× PA/PN), and palliative-reacting (× PN/PA) were associated with decreased T-CAPE, while passive-reacting (× EN) increased it. In males, avoidance (× SA/PA) and passive-reacting (× PN) were associated with increased T-CAPE. Conclusions: Sex differences in the associations of PE with CA and coping underscore the necessity for sex-specific interventions that promote adaptive coping strategies.

27 June 2025 in ALPHA PSYCHIATRY
Verified
Journal Article
Open access
MDMelike Karaçam Doğan
Melike Karaçam Doğan
SGSinan Guloksuz
Sinan Guloksuz

26 June 2025 in BJPsych Open
Verified
Journal Article
Open access
PDF file
MDMelike Karaçam Doğan
Melike Karaçam Doğan
YAYağmur Karakuş Aydos
Yağmur Karakuş Aydos
ŞKŞükrü Keleş
Şükrü Keleş
HEHalime Tuna Çak Esen
Halime Tuna Çak Esen
MYMevhibe İrEm Yildiz
Mevhibe İrEm Yildiz
Background: The transfer from child and adolescent mental health services (CAMHS) to adult mental health services (AMHS) can be challenging, particularly for adolescents with neurodevelopmental disorders (NDDs) requiring long-term follow-up. Aims: To examine the transfer process from CAMHS to AMHS in a university hospital in Türkiye, focusing on challenges, service gaps and barriers to transfer for individuals with NDDs. Method: Hospital records of children with NDDs followed in CAMHS for at least 5 years were reviewed. Children with at least one annual admission until 2017–2018 were included. A total of 211 patients were categorised into two groups: those who transferred to AMHS by 2018–2019 (transferred group, 81 patients) and those who did not transfer (non-transferred group, 130 patients). Clinical features, such as primary diagnosis and treatments, were compared, and parental views on the transfer process were collected via telephone interviews. Results: The transferred group included 81 patients (38.4%), whereas the non-transferred group had 130 patients (61.6%). Of the total sample, 55 (26.1%) were female, and 156 (73.9%) were male. Primary diagnoses were similar between groups; however, the transferred group had more comorbidities (P < 0.001) and more frequent antipsychotic prescriptions (P = 0.006). Proactive information from CAMHS doctors (B = 2.46, s.e. = 0.68, P < 0.001) and psychiatric comorbidities predicted transfer. In addition, attention-deficit hyperactivity disorder diagnoses changed during transfer in the transferred group (P = 0.002). Conclusion: These findings emphasise the need for tailored transition support to enhance mental healthcare for NDD patients and indicate areas where further research is required to address healthcare barriers.

7 December 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
MDMelike Karacam Dogan
Melike Karacam Dogan
EÖEsra Özkan
Esra Özkan
AKAhmet Alp Karakaşlı
Ahmet Alp Karakaşlı
HZHatice Yağmur Zengin
Hatice Yağmur Zengin
DÇDuygu Çap
Duygu Çap
YAYavuz Ayhan
Yavuz Ayhan